Trial
NCT03058939
Assessing the Response Rate of Neo-adjuvant Paclitaxel (Taxol) in Nigerian Women With Breast Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Breast Cancer
Intervention
Paclitaxel
Why stopped
Study never activated to enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-22